Nicolet Advisory Services’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Nicolet Advisory Services’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-333	Closed	-$31K	–	217
2020 Q2	$31K	Hold	333	–	–	﹤0.01%	206
2020 Q1	$10K	Buy	+333	New	+$12.9K	﹤0.01%	195

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Nicolet Advisory Services's VBIV Position: Q3 2020 in Review

Nicolet Advisory Services sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2020, closing a stake of 333 shares — an estimated $31K sold.

Nicolet Advisory Services first reported a position in VBIV in Q1 2020 and held it in 2 quarters. The position peaked at $31K in Q2 2020. 114 funds tracked by Wall St. Rank hold VBIV as of Q3 2020.

Nicolet Advisory Services reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2020 after selling out during the quarter.
Nicolet Advisory Services sold 333 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2020, an estimated $31K.
Nicolet Advisory Services first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q1 2020 and held it in 2 quarters.
Nicolet Advisory Services's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $31K in Q2 2020.
114 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2020.

Based on Nicolet Advisory Services's 13F filing for Q3 2020, filed 27 Oct 2020.